Dr. Philip Reed Wills McDonagh III, MD, PhD

Dr. McDonagh practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. McDonagh's NPI, 1003308412, was assigned on May 31, 2018. Dr. McDonagh holds Maryland license D0100561.

Dr. McDonagh's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. McDonagh's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. McDonagh is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is University of Maryland Radiation Oncology Associates. Dmand AI also links Dr. McDonagh to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McDonagh practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. McDonagh's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. McDonagh is licensed in Maryland.

CMS data shows 167 Medicare services from Dr. McDonagh across 2 procedure codes in 2024, for 106 Medicare patients. Medicare paid $73,050 for them.

CMS counts 106 Medicare patients who saw Dr. McDonagh in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McDonagh's median patient age at 64, with 43% women.

In 2024, Dr. McDonagh wrote 35 Medicare Part D claims for 15 patients. 97% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $228 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

Dr. McDonagh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. McDonagh, published from 2013 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Lung Neoplasms and Positron-Emission Tomography. Dr. McDonagh's most frequent co-authors are Justin Darrell Anderson, MD, Emma Charlotte Fields, MD and Alexander N. Slade, MD, PhD.

CMS Open Payments shows 3 general payments to Dr. McDonagh from 1 drug or device company from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $205.